|
|
Article: Olopatadine 0.2% provides extended efficacy during peak pollen periods
- Article from:
- Ophthalmology Times
- Article date:
- August 15, 2004
- Author:
CopyrightCopyright Advanstar Communications, Inc. Aug 15, 2004. Provided by ProQuest LLC. (Hide copyright information)
|
New formulation
Olopatadine 0.2% provides extended efficacy during peak pollen periods
Once-daily dosing regimen is especially convenient for patients who wear contact lenses
Reviewed by Jack Greiner, DO, PhD
Fort Lauderdale, FL-A new formulation of an anti-allergy medication, olopatadine HCl ophthalmic solution 0.2% (Patanol II, Alcon Laboratories), provides two important advantages. It allows once-daily dosing, which increases patient compliance, and maintains the level of effectiveness of the original formulation, olopatadine 0.1%, during peak pollen seasons for an extended period up to 24 hours, according to Jack Greiner, DO, PhD.
Dr. Greiner is a clinical instructor in ophthalmology, ...